Zhi Li

机构：Soochow University, Zigong First People's Hospital, First Affiliated Hospital of Soochow University, First Affiliated Hospital Zhejiang University · ORCID：0000-0002-9377-2602

发表论文 37 篇 · 总被引 596 次 · h-index 13

代表论文

• Deep Learning Predicts Overall Survival of Patients With Unresectable Hepatocellular Carcinoma Treated by Transarterial Chemoembolization Plus Sorafenib (2020 · Frontiers in Oncology · 被引 43)
• Imaging Changes and Clinical Complications After Drug-Eluting Bead Versus Conventional Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma: Multicenter Study (2020 · American Journal of Roentgenology · 被引 36)
• Effect of microwave ablation treatment of hepatic malignancies on serum cytokine levels (2020 · BMC Cancer · 被引 31)
• EGFL7 promotes hepatocellular carcinoma cell proliferation and inhibits cell apoptosis through increasing CKS2 expression by activating Wnt/β‐catenin signaling (2018 · Journal of Cellular Biochemistry · 被引 31)
• Prognostic Performance of Albumin–Bilirubin Grade With Artificial Intelligence for Hepatocellular Carcinoma Treated With Transarterial Chemoembolization Combined With Sorafenib (2020 · Frontiers in Oncology · 被引 21)
• Preoperative CECT-based Radiomic Signature for Predicting the Response of Transarterial Chemoembolization (TACE) Therapy in Hepatocellular Carcinoma (2022 · CardioVascular and Interventional Radiology · 被引 18)